Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash used in operating activities | (9,060) | (198,335) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds from sale of equipment | — | 326 |
| Purchases of long-lived assets | (422) | (4,167) |
| Purchases of investments | (510,473) | (366,065) |
| Maturities and sales of investments | 325,588 | 553,180 |
| Net cash (used in) provided by investing activities | (185,307) | 183,274 |
| CASH FLOWS FROM FINANCING ACTIVITIES: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s capex?
- Vir Biotechnology, Inc. (VIR) reported capex of $32K in Q2 2026.
- How has Vir Biotechnology, Inc.'s capex changed year-over-year?
- Vir Biotechnology, Inc.'s capex decreased by 98.7% year-over-year, from $2.54M to $32K.
- What is the long-term trend for Vir Biotechnology, Inc.'s capex?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s capex has grown at a -31.4% compound annual growth rate (CAGR), from $21.82M to $4.83M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Vir Biotechnology, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude